Navigation Links
Questcor to Present at the Maxim Group Growth Conference
Date:11/16/2010

ANAHEIM, Calif., Nov. 16, 2010 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced today that it will present at the Maxim Group Growth Conference at 4:00 p.m. ET on Thursday, November 18, 2010 at the Grand Hyatt Hotel in New York. Don M. Bailey, President and Chief Executive Officer, will review the Company's business strategy and recent corporate developments.

Attendance at this conference is by invitation only. A live audio and slides webcast of Questcor's presentation may be accessed through the Company's website at www.questcor.com. An archived replay of the presentation will be available for 90 days after the live presentation, and can also be accessed at www.questcor.com.

About Questcor

Questcor Pharmaceuticals, Inc. is a biopharmaceutical company whose products help patients with serious, difficult-to-treat medical conditions.  Questcor's primary product is H.P. Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indications.  Of these 19 indications, Questcor currently generates substantially all of its net sales from two indications: the treatment of acute exacerbations of multiple sclerosis in adults and the treatment of infantile spasms in children under two years of age.  Questcor is also implementing plans to commercialize Acthar for use in treating nephrotic syndrome, another on-label indication. Specifically with respect to nephrotic syndrome, the FDA has approved Acthar to "induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus." Questcor also markets Doral(R) (quazepam), which is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. For more information, please visit www.questcor.com.


'/>"/>
SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Questcor Reports Third Quarter 2010 Results
2. Questcor to Present at the 21st Annual Oppenheimer Healthcare Conference
3. Questcor Teams With Child Neurology Foundation (CNF) to Fund Infantile Spasms Scientific Research
4. Questcor and Child Neurology Foundation Support the 2nd Annual Infantile Spasms (IS) Awareness Week
5. Questcor to Present at UBS Global Life Sciences Conference
6. Mitchell J. Blutt, M.D. Appointed to Questcor Board of Directors
7. Questcor Receives Notification of PDUFA Date Extension to September 11, 2010
8. Questcor to Present at the Jefferies 2010 Global Life Sciences Conference
9. Trading Halted Today in Questcor Pharmaceuticals Common Stock
10. Questcor to Discuss Results From FDA Panel Meeting
11. Questcor Reports Solid Fourth Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/19/2017)... 2017  Mako Medical Laboratories partnered with Secretary Strickland, ... Assistance Fund (MFA) to bring 140 soldiers back home ... their families one last time before being deployed. Mako ... and logistics needed for these soldiers. "Mako Medical Laboratories ... families. We just wish we could bring them all ...
(Date:7/14/2017)... 2017 Endo International plc (NASDAQ: ENDP ) ... 2017.  Members of its senior management team will host a conference ... a.m. ET. The dial-in number to access the ... 509-7598, and the passcode is 45397076. Please dial in 10 minutes ... A replay of the call will be available from ...
(Date:7/13/2017)... FREMONT, Calif. , July 13, 2017 RK ... (CA) Board of Pharmacy certification for its Fremont, ... chain support solutions in the Tri-Valley and San ... The City of Fremont , with its ... Logistics Group to provide such a powerful resource to the ...
Breaking Medicine Technology:
(Date:7/25/2017)... ... ... “Now Hiring!” is a popular phrase at Home Delivery Incontinent Supplies ... for over 30 consecutive years and now plans to hire more than 100 people ... and growth at HDIS, following the company’s acquisition by Fortune 1000 company Domtar. HDIS ...
(Date:7/25/2017)... Beach, Florida (PRWEB) , ... July 25, 2017 ... ... employee, Jennifer Haller, to the sales department joining as Regional Account Manager for ... relationships with contracted customers in the liquidation of their obsolete medical assets. , ...
(Date:7/25/2017)... , ... July 25, 2017 , ... ... assistance and finance management services to communities across North Carolina, is launching a ... Network to raise community support for the ongoing fight against bladder cancer. , ...
(Date:7/25/2017)... ... July 25, 2017 , ... Dr. Donna Bergman, professor of ... and published an article in the medical science journal Physical Medicine and Rehabilitation ... article and the research that helped produce it, were written and conducted in ...
(Date:7/25/2017)... ... July 25, 2017 , ... Dr. Gina Negrette, a skilled ... than a decade of experience in psychiatry, treating clients in diverse settings, including ... disorders, psychotic and manic conditions, as well as those who were fighting simply ...
Breaking Medicine News(10 mins):